MONITOR-HF trial presented in a late breaking science session at Heart Failure 2023
News | Heart Failure
Remote Monitoring Reduces Heart Failure Hospitalizations and Improves Quality of Life

May 23, 2023 — The first investigator-initiated study of remote pulmonary artery pressure monitoring has found that it ...

Home May 23, 2023
Home
Findings from two new studies highlight the success of left bundle branch area pacing (LBBAP), or his-bundle pacing (HBP) as an alternative to biventricular pacing (BVP) for patients requiring cardiac resynchronization therapy (CRT).
News | Cardiac Resynchronization Therapy Devices (CRT)
New Clinical Trials Demonstrate Benefits of Left Bundle Branch Area Pacing Compared to Standard Biventricular Pacing

May 22, 2023 — Findings from two new studies highlight the success of left bundle branch area pacing (LBBAP), or his ...

Home May 22, 2023
Home
Results from a pivotal clinical trial found a leadless pacemaker can deliver cardiac resynchronization therapy (CRT) among patients who were not able to be treated with conventional CRT and epicardial leads.
News | Cardiac Resynchronization Therapy Devices (CRT)
The WiSE CRT System Offers an Endocardial Alternative to Conventional CRT

May 22, 2023 — Results from a pivotal clinical trial found a leadless pacemaker can deliver cardiac resynchronization ...

Home May 22, 2023
Home
Signify Research industry analyst drives home the importance of being well informed of existing technology and prepare the necessary due diligence to ensure their solution is not infringing on existing technological patents
Feature | Wearables | By Kelly Patrick
AliveCor Vs Apple Battle Continues

The use of wearable technology in healthcare is continuing to evolve with high interest, driving technology innovation ...

Home May 22, 2023
Home
Results from global trial of the POLARx Cryoablation System* meet safety and effectiveness endpoints
News | Left Atrial Appendage (LAA) Occluders
Real-world outcomes from the EU-PORIA registry of the FARAPULSE Pulsed Field Ablation (PFA) System

May 22, 2023 — Boston Scientific Corporation announced data supporting use of the company's key electrophysiology and ...

Home May 22, 2023
Home
Findings from a study examining the relationship between marijuana use and peripheral artery disease (PAD) were presented during the Society for Cardiovascular Angiography & Interventions (SCAI) 2023 Scientific Sessions, held May 18-20 in Phoenix, AZ. Results found marijuana users are at a significantly increased risk of developing PAD, compared to the general population.
News | SCAI
Marijuana Users Three Times More Likely to Develop Peripheral Artery Disease

May 19, 2023 — Findings from a study examining the relationship between marijuana use and peripheral artery disease (PAD ...

Home May 19, 2023
Home
The platform is designed to expand the information available to clinicians prescribing the Epi+Gen CHD and PrecisionCHD laboratory developed tests (LDTs)
News | Artificial Intelligence
Cardio Diagnostics Holdings, Inc’s Actionable Clinical IntelligenceTM (ACI) Platform Offers New Epigenetic and Genetic Insights to Inform Coronary Heart Disease Management

May 19, 2023 — Cardio Diagnostics Holdings, Inc, an artificial intelligence-powered precision cardiovascular medicine ...

Home May 19, 2023
Home
Figure 1. Results from the PROTECT II RCT, PROTECT III and RESTORE-EF Pooled Data Analysis
News | Intra-Aortic Balloon Pumps (IABP)
Analysis Showcases Potential for More Complete Revascularizations with Impella Compared to IABP during HRPCI

May 19, 2023 — Abiomed, part of Johnson & Johnson MedTech[1], announces results of a third-party analysis showing that ...

Home May 19, 2023
Home
Data presented at EuroPCR 2023 build on prior study results demonstrating TriClip is a safe and effective therapy to treat leaky tricuspid valves
News | Structural Heart
New Late-breaking Data Reinforce the Benefits of Abbott's TriClip Device for People with Tricuspid Valve Disease

May 19, 2023 — Abbott announced late-breaking data that add to the body of clinical evidence supporting the benefits of ...

Home May 19, 2023
Home
Assert-IQ\ ICM is the world’s longest lasting Bluetooth - enabled insertable cardiac monitor
News | Implantable Cardiac Monitor (ICM)
Abbott Receives FDA Clearance for Assert-IQ Insertable Cardiac Monitor 

May 18, 2023 — Abbott announced its Assert-IQ insertable cardiac monitor (ICM) has received U.S. Food and Drug ...

Home May 18, 2023
Home
The first of Vektor Medical's new studies, being presented at HRS 2023, showcases vMap’s utility in unstable ventricular tachycardia (VT) ablation. (Graphic: Business Wire)
News | Atrial Fibrillation
Vektor Medical Releases Compelling Results for vMap Utility

May 18, 2023 — Vektor Medical, pioneers of technology to accurately map arrhythmias using only 12-lead ECG data ...

Home May 18, 2023
Home
54-year-old patient with COVID-19 who underwent full angiographic reperfusion (extended thrombolysis in cerebral ischemia score = 3) after acute ischemic stroke. Top: Automated readout summary of CT perfusion data at presentation shows large mismatch volume (54 mL). Bottom: Follow-up MR image shows progression in infarction growth, with final infarction volume of approximately 72 cm3 (600% increase from CT perfusion imaging estimate of 9 mL shown in A). 
News | Coronavirus (COVID-19)
Infarction Growth, Penumbral Consumption After Reperfusion in COVID Vaccine-Naïve Patients

May 18, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR), SARS ...

Home May 18, 2023
Home
Jasmina Brooks
News | Atrial Fibrillation
Jasmina Brooks Named President of Biosense Webster

May 17, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmiatreatment and part of Johnson & Johnson ...

Home May 17, 2023
Home
R-One+ is a robotic solution that allows the interventional cardiologist to perform coronary angioplasties by controlling the devices using an integrated control command unit located in the cathlab or in the control room
News | Robotic Systems
Robocath Launches New Robotic Platform R-One+

May 17, 2023 — Robocath, a company that designs, develops and commercializes smart robotic solutions for the treatment ...

Home May 17, 2023
Home
Edwards Lifesciences announced that new data from the Benchmark Registry in Europe demonstrated the safety and effectiveness of this streamlined treatment pathway for patients receiving transcatheter aortic valve replacement (TAVR) with balloon-expandable valves.
News | Structural Heart
Data from Benchmark Registry Demonstrate Improved TAVR Efficiency with Preserved Patient Safety

May 17, 2023 — Edwards Lifesciences announced that new data from the Benchmark Registry in Europe demonstrated the ...

Home May 17, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now